Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Harpoon Therapeutics, Inc.Listing unverified | Buy | $4M | conv 51First in 12mo | SEC | |
Harpoon Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Harpoon Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Harpoon Therapeutics, Inc.Listing unverified | Other | n/a (No price was disclosed in the filing) | SEC | ||
Harpoon Therapeutics, Inc.Listing unverified | Buy | $3M | conv 59ClusterFirst in 12mo | SEC | |
Harpoon Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Harpoon Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Harpoon Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Harpoon Therapeutics, Inc.Listing unverified | Buy | $3M | conv 46ClusterFirst in 12mo | SEC |